Hepacore Ltd.
Records under this name other than the patents Hepacore Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 5 of 5 · Back to Hepacore Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,226,949 | FGF-18 truncated variants having increased receptor specificity and uses thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,298,528 | Methods for bone regeneration using endothelial progenitor cell preparations Lapsed on the fee record Ended Oct 30, 2024 · From the USPTO record | Lapsed on the fee record | Ended Oct 30, 2024 | From the USPTO record |
| US 7,887,831 | Bone Enhancing Composite Formerly held Lapsed on the fee record Ended Feb 15, 2023 · High confidence | Lapsed on the fee record | Ended Feb 15, 2023 | High confidence |
| US 7,276,481 | Method and Composition for Treatment of Skeletal Dysplasias Term ended Term ended Jan 25, 2023 · High confidence | Term ended | Term ended Jan 25, 2023 | High confidence |
| US 6,265,632 | Animal model for fibroblast growth factor receptor associated chondrodysplasia Term ended Term ended Aug 26, 2019 · From the USPTO record | Term ended | Term ended Aug 26, 2019 | From the USPTO record |